EGFR and breast cancer: Regarding the apparent copper inactivation specificity of PTPN2 over PTPN1, a more comprehensive analysis of PTP siRNA knockdowns in MCF7 breast cancer cells also found PTPN2 knockdown significantly diminished EGFR activation by EGF, while PTPN1 knockdown had no effect48.